Mark S. Schroeder - 02 Feb 2023 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role
EVP, President-Diagnostics Lab
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Mark S. Schroeder
Issuer symbol
LH
Transactions as of
02 Feb 2023
Net transactions value
-$112,607
Form type
4
Filing time
06 Feb 2023, 14:51:51 UTC
Previous filing
10 Nov 2022
Next filing
07 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LH Common Stock Options Exercise +443 +6.6% 7,130 02 Feb 2023 Direct F1
transaction LH Common Stock Tax liability $30,344 -119 -1.7% $254.99 7,011 02 Feb 2023 Direct F2
transaction LH Common Stock Sale $82,264 -324 -4.6% $253.90 6,687 03 Feb 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Restricted Stock Unit Options Exercise $0 -443 -16% $0.000000 2,274 02 Feb 2023 Common Stock 443 Direct F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2 Stock withholding to satisfy tax withholding obligations.
F3 Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
F4 The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022.
F5 This number reflects the aggregate number of Restricted Stock Units held by the reporting person.